NCT07301710

Brief Summary

The overall purpose of this study is to compare changes in sleep outcomes in people with obstructive sleep apnea (OSA) depending on their participation in one of two behavioral interventions; both involve drinking water and breathing. A second purpose is to compare outcomes between people who have sustained a traumatic brain injury (TBI) and those with no history of TBI. The main questions it aims to answer are whether sleep quality improves after 3-months of high-resistance versus low-resistance exercises, and whether people have different outcomes depending on their history of TBI.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P75+ for phase_1

Timeline
16mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Jan 2026Dec 2027

First Submitted

Initial submission to the registry

November 5, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 24, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

January 29, 2026

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

February 17, 2026

Status Verified

December 1, 2025

Enrollment Period

1.6 years

First QC Date

November 5, 2025

Last Update Submit

February 11, 2026

Conditions

Keywords

Obstructive Sleep ApneaMyofunctional TherapyTraumatic Brain InjuryRandomized Controlled TrialOropharyngeal ExercisesRespiratory Resistance Training

Outcome Measures

Primary Outcomes (1)

  • Apnea-Hypopnea Index (AHI)

    AHI is the number of apneic and hypopneic episodes per hour of sleep. The scores start at zero, meaning no events are taking place. A mild score falls in the range of 5-15; moderate 15-30, and a severe diagnosis is 30 or more events per hour. Pre-intervention AHI is obtained from standard-of-care in-clinic sleep study. Post-intervention AHI is obtained from an in-clinic sleep study conducted as part of this research.

    From enrollment to end of three-month intervention

Secondary Outcomes (4)

  • SpO2

    From enrollment to end of three-month intervention

  • Snore Index

    From enrollment to end of three-month intervention

  • Epworth Sleepiness Scale (ESS)

    From enrollment to end of three-month intervention with option for additional three-week follow-up

  • Functional Outcomes of Sleep Questionnaire-10 (FOSQ-10)

    From enrollment to end of three-month intervention with option for additional three-week follow-up

Other Outcomes (4)

  • Tongue Strength

    From enrollment to end of three-month intervention with option for additional three-week follow-up

  • Tongue Endurance

    From enrollment to end of three-month intervention with option for additional three-week follow-up

  • Maximal Inspiratory Pressure (MIP)

    From enrollment to end of three-month intervention with option for additional three-week follow-up

  • +1 more other outcomes

Study Arms (2)

Myofunctional Therapy

EXPERIMENTAL
Behavioral: High-Resistance Breathing and Drinking Exercises

Relaxation Therapy

SHAM COMPARATOR
Behavioral: Low-Resistance Breathing and Drinking Exercises

Interventions

Three months of drinking at least 32-oz of water daily through a high-resistance nozzle, and inhaling and exhaling 60 times per day through a high-resistance breathing device

Also known as: Device-Assisted Myofunctional Therapy
Myofunctional Therapy

Three months of drinking 32-oz of water daily through a low-resistance nozzle, and inhaling and exhaling 40 times per day through a low-resistance breathing device

Also known as: Placebo Therapy
Relaxation Therapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • New diagnosis of OSA (AHI, ≥ 5) or failure of first-line OSA treatment;
  • Willingness to forego first-line OSA treatment or stop current OSA treatment for 3 months;
  • Ability to follow directions and perform the required exercises;
  • Age between 18-65 yr.

You may not qualify if:

  • Current use of OSA treatment;
  • Medical comorbidities that require restricting fluid intake (e.g., dysphagia, renal disease, liver disease, hyponatremia);
  • Severe nasal obstruction; 4) severe ankyloglossia; 4) craniofacial abnormality; 5) severe pulmonary disease; 6) severe post-traumatic stress disorder; 7) very severe insomnia; 8) body mass index (BMI) ≥30 kg/m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Walter Reed National Military Medical Center

Bethesda, Maryland, 20889, United States

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, ObstructiveBrain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesBrain InjuriesBrain DiseasesCentral Nervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Central Study Contacts

Nancy P. Solomon, Ph.D.

CONTACT

Kathleen M. Moran, Ed.D

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2025

First Posted

December 24, 2025

Study Start

January 29, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

February 17, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

Per a Data Sharing Agreement, de-identified primary and secondary outcome data from Walter Reed National Military Medical Center will be shared with investigators at Uniformed Services University of the Health Sciences, contractors with the Geneva Foundation, and colleagues at University of Minnesota (UMN). UMN colleagues are conducting a concurrent study using the same procedures as the experimental arm; both sites plan to pool data for a larger sample size.

Shared Documents
STUDY PROTOCOL
Time Frame
The study protocol was developed during grant-proposal preparation. Investigators communicate regularly to share updates and coordinate procedures for study implementation. IPD will be made available periodically throughtout data-collection and during data analysis and dissemination (anticipated Jan 2026 -- Dec 2028).
Access Criteria
The WRNMMC/USUHS research team will share coded data with project-related Geneva Foundation contractors and UMN collaborators. The coded data will be stored on REDCap, housed on an encrypted password- and firewall-protected server. Authorized project personnel may request IPD through the PIs.

Locations